Research and Markets: The Blood Glucose Test Strips Market Segment Is Expected To Be Valued At $10.9 Billion in 2017 Says Latest Study

DUBLIN--()--Research and Markets(http://www.researchandmarkets.com/research/9b6116/blood_glucose_moni) has announced the addition of GlobalData's new report "Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" to their offering.

GlobalData's new report, Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 provides key data, information and analysis on the global blood glucose monitoring devices market.

The global blood glucose monitoring market was estimated to be worth $8.9 billion in 2010. The market value has risen from $6.2 billion in 2003, at a Compound Annual Growth Rate (CAGR) of 5.2%. The blood glucose test strips market segment was the largest segment, valued at $7.9 billion in 2010, and has registered a CAGR of 5.3% since 2003.

The global blood glucose monitoring devices market is expected to reach a value of $12.2 billion in 2017, with a predicted CAGR of 4.5% between 2010 and 2017. The blood glucose test strips market segment is expected to be valued at $10.9 billion in 2017 and is forecast to exhibit a CAGR of 4.6% between 2010 and 2017. High Prevalence of Diabetes is Leading to Patients Opting for Blood Glucose Monitoring Devices

The International Diabetes Federation (IDF) estimates that about 366 million people around the world were suffering from diabetes in 2011, representing 8.3% of the global population. This is expected to increase to 9.9% by 2030. Developed countries tend to have a high prevalence of diabetes. For example, 10.9% of people in the US suffer from diabetes, the highest rate in the world. China, however, has the largest total number of diabetics, with an estimated 90 million suffering from the disease. In India, diabetes affects over 61 million inhabitants.

Companies Mentioned:

  • F. Hoffmann-La Roche Ltd
  • LifeScan, Inc.
  • Bayer HealthCare AG
  • Abbott Laboratories.

For more information visit http://www.researchandmarkets.com/research/9b6116/blood_glucose_moni

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716